Rockville, MD · Founded 2021 · Privately Held (backing)
Developer of a biotechnology platform designed to support the development and commercialization of advanced therapies. Ascend (Drug Discovery) is based in Rockville, MD and was founded in 2021. Its last known valuation is $151 million. It has raised $194 million.
Last price · $/share
—
Implied valuation
$150.9M
Total raised
$194.3M
Last round
—
Team — not yet on record
No current team members for Ascend (Drug Discovery) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ascend (Drug Discovery) with a free account
·The complete investor list: 13 names
·Watch Ascend (Drug Discovery): the Monday email on marks, rounds and moves
